Abdolkarim Mahrooz

The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?

Atena Variji, Yasaman Shokri, Samane Fallahpour et al. · Atherosclerosis · 2018 · 42 citations

Oxysterol, Biochemistry, Cardiovascular Disease +10

The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin

Zahra Kashi, Abdolkarim Mahrooz, Anvarsadat Kianmehr et al. · PLoS ONE · 2016 · 37 citations · Full text

The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study

Abdolkarim Mahrooz, Hassan Parsanasab, Mohammad Bagher Hashemi‐Soteh et al. · Clinical and Experimental Medicine · 2014 · 34 citations

Metabolic Syndrome, Diabetes Management, Diabetes +7

Impact of ATM and SLC22A1 Polymorphisms on Therapeutic Response to Metformin in Iranian Diabetic Patients.

Hamid Ghaedi, Soudeh Ghafouri‐Fard, Abolfazl Movafagh et al. · PubMed · 2016 · 33 citations · Full text

Obesity, Metabolic Syndrome, Iranian Diabetic Patients +14

The variant organic cation transporter 2 (OCT2)–T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin

Zahra Kashi, Parisa Masoumi, Abdolkarim Mahrooz et al. · Diabetes Research and Clinical Practice · 2015 · 27 citations

Insulin Resistance, Molecular Pharmacology, Metabolic Syndrome +12